Unravelling the Etiology of Shoulder Osteoarthritis
Key facts
- Who runs it
- Ottawa Hospital Research Institute
- Where
- Canada2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 60 people, planned
- Started
- 23 Jun 2021
- Expected to end
- Dec 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Low-dose CT
- T1Rho MRI
- Motion Analysis
- Record updated
- 4 July 2025
Who can take part
- Age
- 18 years to 59 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Adults <60 years of age
- Posterior humeral head subluxation >55% (determined from imaging)
Who cannot take part
- History of shoulder instability
- History of shoulder trauma including fracture
- Neurological disorders of the upper limb
- >60 years of age
- Imaging evidence of humeral head or glenoid bony deformity
- Rotator cuff pathology
- Labral pathology
- Pre-existing joint deformity (OA) cases greater than grade I (as per Samilson and Prieto)
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Osteoarthritis (OA) is a progressive disease resulting from the degradation of synovial joint articular cartilage over time.
Read full original descriptionShow less
The hallmark symptom is diffuse aching and progressive pain made worse with activity. Loss of range of motion and compromised function inevitably follow. This degenerative disease can affect the shoulder joint. When symptoms become refractory to conservative treatment such as anti-inflammatory medication, steroid injections, activity modification or physical therapy; surgery (total or reverse shoulder arthroplasty) may be considered.
Idiopathic shoulder OA is typically characterized by posterior subluxation of the humeral head upon the glenoid and posterior bone loss. An imbalance in the application of forces applied to the proximal humerus by the posterior and anterior rotator cuff muscles has been postulated to be the leading cause of idiopathic shoulder OA. However, there is only preliminary evidence to support this theory and the etiology of this pattern of deformity is unknown. The theory the posterior humeral head subluxation is a precursor to OA is only supported by very low-level evidence and no longitudinal studies have been conducted. As a result, the cause and natural history of shoulder OA remains unknown.
Research into this area is urgently needed to generate knowledge that will inform future treatments aimed at modifying and slowing the progression of shoulder OA and to reduce the need for shoulder replacement therapy.
The aim of this project is to develop an understanding of the pathophysiology of shoulder OA.
The 2 groups in the trial
- Group 1: Early Degeneration ('Disease')Treatment being tested
Those who have posterior subluxation of the humeral head and show early signs of degeneration in their shoulder.
Treatment: Low-dose CT, T1Rho MRI, and Motion Analysis
- Group 2: No Degeneration ('Healthy')Existing treatment, for comparison
Those who have posterior subluxation of the humeral head and show no signs of degeneration.
Treatment: Low-dose CT, T1Rho MRI, and Motion Analysis
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 4 July 2025